Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Clin Oral Implants Res. 2013 Feb 27;25(7):803–812. doi: 10.1111/clr.12139

Table 3.

Salivary Protein Biomarkers for Diabetic and Control Patients

Biomarker log10(pg/mL) Group Baseline 12-months
IL-2 Control 1.31 ± 0.21 1.06 ± 0.22
Diabetes 0.76 ± 0.22 0.85 ± 0.28
IL-6 Control 1.42 ± 0.18 1.41 ± 0.18
Diabetes 1.41 ± 0.18 1.21 ± 0.25
IL-8 Control 3.20 ± 0.03 3.21 ± 0.04
Diabetes 3.24 ± 0.05 3.17 ± 0.07
TNF-α Control 1.68 ± 0.24 1.89 ± 0.13
Diabetes 1.24 ± 0.31 1.44 ± 0.28
INF-γ Control 1.05 ± 0.16 0.92 ± 0.20
Diabetes 0.93 ± 0.18 0.69 ± 0.23
CRP Control 3.01 ± 0.29 2.82 ± 0.30
Diabetes 2.93 ± 0.32 2.99 ± 0.30
MIP-1α Control 2.74 ± 0.20 2.81 ± 0.15
Diabetes 2.85 ± 0.28 2.71 ± 0.30
MIP-1β Control 0.86 ± 0.11 0.83 ± 0.10
Diabetes 0.81 ± 0.13 0.88 ± 0.15
MMP-1 Control 3.95 ± 0.15 4.07 ± 0.11
Diabetes 4.01 ± 0.11 4.09 ± 0.17
MMP-2 Control 2.70 ± 0.16 2.51 ± 0.23
Diabetes 2.24 ± 0.24 1.94 ± 0.39
MMP-9 Control 4.26 ± 0.04 4.29 ± 0.04
Diabetes 4.32 ± 0.05 4.24 ± 0.07
TIMP-2 Control 3.90 ± 0.02 3.88 ± 0.03
Diabetes 3.92 ± 0.04 3.90 ± 0.06
ProCT Control 0.88 ± 0.23 1.08 ± 0.20
Diabetes 1.33 ± 0.23 0.94 ± 0.25

Values are means +/− SE: Standard error